|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Banumathy G and Cairns P: Signaling
pathways in renal cell carcinoma. Cancer Biol Ther. 10:658–664.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pantuck AJ, Zisman A and Belldegrun AS:
The changing natural history of renal cell carcinoma. J Urol.
166:1611–1623. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel D: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yi Z, Fu Y, Zhao S, Zhang X and Ma C:
Differential expression of miRNA patterns in renal cell carcinoma
and nontumorous tissues. J Cancer Res Clin Oncol. 136:855–862.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
White NM, Bao TT, Grigull J, Youssef YM,
Girgis A, Diamandis M, Fatoohi E, Metias M, Honey RJ, Stewart R, et
al: miRNA profiling for clear cell renal cell carcinoma: Biomarker
discovery and identification of potential controls and consequences
of miRNA dysregulation. J Urol. 186:1077–1083. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meng X, Chen X, Chen D, Bing Y and Huang
Z: FoxO1: A novel insight into its molecular mechanisms in the
regulation of skeletal muscle differentiation and fiber type
specification. Oncotarget. 8:10662–10674. 2017.PubMed/NCBI
|
|
8
|
Wang C, Hu J, Lu M, Gu H, Zhou X, Chen X,
Zen K, Zhang CY, Zhang T, Ge J, et al: A panel of five serum miRNAs
as a potential diagnostic tool for early-stage renal cell
carcinoma. Sci Rep. 5:76102015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou W, Bi X, Gao G and Sun L: miRNA-133b
and miRNA-135a induce apoptosis via the JAK2/STAT3 signaling
pathway in human renal carcinoma cells. Biomed Pharmacother.
84:722–729. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Z, Tang ZY, He Y, Liu LF, Li DJ and
Chen X: miRNA-205 is a candidate tumor suppressor that targets ZEB2
in renal cell carcinoma. Oncol Res Treat. 37:6582014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang X, Huang M, Kong L and Li Y: miR-372
suppresses tumour proliferation and invasion by targeting IGF2BP1
in renal cell carcinoma. Cell Prolif. 48:593–599. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiong F, Liu K, Zhang F, Sha K, Wang X,
Guo X and Huang N: miR-204 inhibits the proliferation and invasion
of renal cell carcinoma by inhibiting RAB22A expression. Oncol Rep.
35:3000–3008. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hidaka H, Seki N, Yoshino H, Yamasaki T,
Yamada Y, Nohata N, Fuse M, Nakagawa M and Enokida H: Tumor
suppressive microRNA-1285 regulates novel molecular targets:
Aberrant expression and functional significance in renal cell
carcinoma. Oncotarget. 3:44–57. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kolde R, Laur S, Adler P and Vilo J:
Robust rank aggregation for gene list integration and
meta-analysis. Bioinformatics. 28:573–580. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Griffiths-Jones S, Saini HK, van Dongen S
and Enright AJ: miRBase: Tools for microRNA genomics. Nucleic Acids
Res. 36:D154–D158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are MicroRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tweedie S, Ashburner M, Falls K, Leyland
P, McQuilton P, Marygold S, Millburn G, Osumi-Sutherland D,
Schroeder A, Seal R and Zhang H: FlyBase Consortium: FlyBase:
Enhancing Drosophila gene ontology annotations. Nucleic Acids Res.
37:D555–D559. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rédei GP: Kyoto Encyclopedia of Genes and
Genomes. John Wiley and Sons, Inc.; Hoboken, NJ: 2012
|
|
19
|
Huang DW, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Redova M, Poprach A, Nekvindova J, Iliev
R, Radova L, Lakomy R, Svoboda M, Vyzula R and Slaby O: Circulating
miR-378 and miR-451 in serum are potential biomarkers for renal
cell carcinoma. J Transl Med. 10:552012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu X, Weng L, Li X, Guo C, Pal SK, Jin JM,
Li Y, Nelson RA, Mu B, Onami SH, et al: Identification of a
4-microRNA signature for clear cell renal cell carcinoma metastasis
and prognosis. PLoS One. 7:e356612012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Osanto S, Qin Y, Buermans HP, Berkers J,
Lerut E, Goeman JJ and van Poppel H: Genome-wide microRNA
expression analysis of clear cell renal cell carcinoma by next
generation deep sequencing. PLoS One. 7:e382982012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nakada C, Matsuura K, Tsukamoto Y,
Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida
T, Sato F, et al: Genome-wide microRNA expression profiling in
renal cell carcinoma: significant down-regulation of miR-141 and
miR-200c. J Pathol. 216:418–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Weng L, Wu X, Gao H, Mu B, Li X, Wang JH,
Guo C, Jin JM, Chen Z, Covarrubias M, et al: MicroRNA profiling of
clear cell renal cell carcinoma by whole-genome small RNA deep
sequencing of paired frozen and formalin-fixed, paraffin-embedded
tissue specimens. J Pathol. 222:41–51. 2010.PubMed/NCBI
|
|
25
|
Gottardo F, Liu CG, Ferracin M, Calin GA,
Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, et
al: Micro-RNA profiling in kidney and bladder cancers. Urol Oncol.
25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Diaz G, Melis M, Tice A, Kleiner DE,
Mishra L, Zamboni F and Farci P: Identification of microRNAs
specifically expressed in hepatitis C virus-associated
hepatocellular carcinoma. Int J Cancer. 133:816–824. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ortholan C, Puissegur MP, Ilie M, Barbry
P, Mari B and Hofman P: MicroRNAs and lung cancer: New oncogenes
and tumor suppressors, new prognostic factors and potential
therapeutic targets. Curr Med Chem. 16:1047–1061. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao Y, Ma X, Yao Y, Li H, Fan Y, Zhang Y,
Zhao C, Wang L, Ma M, Lei Z and Zhang X: miR-155 regulates the
proliferation and invasion of clear cell renal cell carcinoma cells
by targeting E2F2. Oncotarget. 7:20324–20337. 2016.PubMed/NCBI
|
|
29
|
Nakada C, Tsukamoto Y, Matsuura K, Nguyen
TL, Hijiya N, Uchida T, Sato F, Mimata H, Seto M and Moriyama M:
Overexpression of miR-210, a downstream target of HIF1α, causes
centrosome amplification in renal carcinoma cells. J Pathol.
224:280–288. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu TY, Zhang H, Du SM, Li J and Wen XH:
Expression of microRNA-210 in tissue and serum of renal carcinoma
patients and its effect on renal carcinoma cell proliferation,
apoptosis, and invasion. Genet Mol Res. 15:150177462016.PubMed/NCBI
|
|
31
|
Song F, Yang D, Liu B, Guo Y, Zheng H, Li
L, Wang T, Yu J, Zhao Y, Niu R, et al: Integrated microRNA network
analyses identify a poor-prognosis subtype of gastric cancer
characterized by the miR-200 family. Clin Cancer Res. 20:878–889.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dhayat SA, Mardin WA, Köhler G, Bahde R,
Vowinkel T, Wolters H, Senninger N, Haier J and Mees ST: The
microRNA-200 family-a potential diagnostic marker in hepatocellular
carcinoma? J Surg Oncol. 110:430–438. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hurteau GJ, Carlson JA, Spivack SD and
Brock GJ: Overexpression of the microRNA hsa-miR-200c leads to
reduced expression of transcription factor 8 and increased
expression of E-cadherin. Cancer Res. 67:7972–7976. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liang J, Zhang Y, Jiang G, Liu Z, Xiang W,
Chen X, Chen Z and Zhao J: MiR-138 induces renal carcinoma cell
senescence by targeting EZH2 and is downregulated in human clear
cell renal cell carcinoma. Oncol Res. 21:83–91. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu D, Niu X, Pan H, Zhou Y, Zhang Z, Qu P
and Zhou J: Tumor-suppressing effects of microRNA-429 in human
renal cell carcinoma via the downregulation of Sp1. Oncol Lett.
12:2906–2911. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li Y, Chen D, Li Y, Jin L, Liu J, Su Z, Qi
Z, Shi M, Jiang Z, Ni L, et al: Oncogenic cAMP responsive element
binding protein 1 is overexpressed upon loss of tumor suppressive
miR-10b-5p and miR-363-3p in renal cancer. Oncol Rep. 35:1967–1978.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tang K and Xu H: Prognostic value of
meta-signature miRNAs in renal cell carcinoma: An integrated miRNA
expression profiling analysis. Sci Rep. 5:102722015. View Article : Google Scholar : PubMed/NCBI
|
